69 related articles for article (PubMed ID: 6199608)
1. Pharmacokinetic-hemodynamic studies of disopyramide.
Abdollah H; Brien JF; Armstrong PW
J Cardiovasc Pharmacol; 1984; 6(1):28-34. PubMed ID: 6199608
[TBL] [Abstract][Full Text] [Related]
2. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
[TBL] [Abstract][Full Text] [Related]
3. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
4. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model.
Kidwell GA; Lima JJ; Schaal SF; Muir WW
J Cardiovasc Pharmacol; 1989 Apr; 13(4):644-55. PubMed ID: 2471004
[TBL] [Abstract][Full Text] [Related]
6. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and acute cardiovascular effects of menogaril in patients with metastatic tumors.
Piergies AA; Benson AB
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):63-9. PubMed ID: 7757312
[TBL] [Abstract][Full Text] [Related]
10. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
Le Corre P; Gibassier D; Sado P; Le Verge R
Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
[TBL] [Abstract][Full Text] [Related]
12. [Experimental studies of the hemodynamics of disopyramide in comparison with quinidine].
Hoffmeister HM; Hepp A; Seipel L
Z Kardiol; 1988 Jan; 77(1):48-52. PubMed ID: 3363980
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
15. [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs].
Zhang ZH; Liu JS; Chu JN; Shang XH; Lin CR; Ma XB; Shi TR; Wang M; Wang YH; Li YR; Liu JH; Wu XY; Zhang XD; Zhang DS; Zhao ZH
Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):1001-5. PubMed ID: 16161429
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog.
Lertora JJ; King LW
J Pharmacol Exp Ther; 1986 Sep; 238(3):893-9. PubMed ID: 2427689
[TBL] [Abstract][Full Text] [Related]
17. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
Wong SL; Barriere SL; Kitt MM; Goldberg MR
J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
[TBL] [Abstract][Full Text] [Related]
19. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
20. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
Segreti JA; Marsh KC; Polakowski JS; Fryer RM
J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
